Excellos Capacity Update July 2025: Cell & Gene Therapy

Excellos leverages its extensive starting material expertise through strategic partnerships as a key differentiator in the competitive CDMO landscape. This presentation explores how our deep understanding of partner-sourced raw materials, quality control, and supply chain management creates significant value for our clients. We'll demonstrate how this facilitates cost savings, timeline reductions, and risk mitigation through our collaborative supplier partnerships.